ATEC Extends InVictus MIS Platform With Commercial Release of InVictus MIS Tower
October 19 2020 - 4:30PM
Alphatec Holdings, Inc. (“ATEC” or the “Company”) (Nasdaq:
ATEC), a medical device company dedicated to revolutionizing the
approach to spine surgery, announced today the commercial release
of the InVictus™ MIS Tower, an elegant and intuitive system
designed for minimally invasive percutaneous
fixation. InVictus MIS Tower is the next evolution of
InVictus™, ATEC’s comprehensive spinal fixation
platform, engineered to treat a range of pathologies with
intraoperative adaptability and surgical predictability through
open, MIS, or hybrid approaches.
“The novel components designed into the InVictus
Platform are the result of ATEC being willing to invest where
others won’t – in the procedural requirements that improve surgical
outcomes,” said Pat Miles, Chairman and Chief Executive Officer.
“The InVictus MIS Tower system is an important addition to our
comprehensive posterior solution as it opens the door for surgeons
to increasingly partner with ATEC for MIS degenerative and
deformity applications. We are committed to continuing to develop
differentiated, integrated solutions in order to expand surgeon
adoption and loyalty, and to better serve patients.”
Developed to enhance the capability of
percutaneous fixation systems, InVictus MIS Tower expands upon the
foundational elements of the InVictus platform allowing for
the treatment of more complex pathologies through a less disruptive
manner. InVictus Tower features two low-profile removable
towers, engineered to reliably stay secured to cannulated dual-lead
polyaxial screws to improve control and to support long construct
manipulation.
When paired with the SingleStep™ technique,
the MIS Tower system extends the dependability and predictability
of InVictus MIS fixation and can obviate the need for guide
wires, which can lead to surgical complications. It seamlessly
integrates with SafeOp™ Neural InformatiX System combined EMG
technology to predictably deliver real-time, actionable information
during pedicle preparation and screw insertion. InVictus MIS Tower
also couples with InVictus MOD and InVictus OPEN to streamline
in situ tulip attachment, acting as an efficient guide for reliable
rod passage and adapting intraoperatively to the surgical
requirements of any procedure.
Tyler G. Smith, MD, of the Sierra Spine
Institute in Roseville, CA, commented, “The InVictus Tower System
has clearly been designed to more reproducibly address complex
pathologies in a less disruptive manner. Its low-profile, yet
robust instrumentation and adaptability take the guesswork out of
minimally invasive surgery. The Tower System integrates
seamlessly with the SingleStep technique and SafeOp Advanced
Neuromonitoring to beget a comprehensive posterior approach that I
can depend on for successful surgical outcomes."
K. Brandon Strenge, MD, an orthopaedic spine
surgeon at the Orthopaedic Institute of Western Kentucky, added,
“Achieving compression through percutaneous incision in either a
short or long construct has long been incredibly challenging. In my
hands, the InVictus Tower Compressor is a game changer. Unlike
other systems I’ve used, the Tower Compressor seats inside the
towers and compresses along the contour of the lordotic rod, easily
inducing compression and enabling me to preserve or create
lordosis as needed per patient.”
Key Features of the
InVictus MIS Tower
System
- Integrates with SafeOp Neural
InformatiX System to predictability provide surgeons with
real-time, actionable information to detect and monitor the health
of nerves at risk during posterior fixation
- Adapts intraoperatively to surgical
requirements with robust instruments and customizable implants
designed to accept multiple rod diameters and materials, which
enables the treatment of more advanced pathologies
- Leverages helical flange tulip
technology to create a dependable construct by reducing
cross-thread potential and helping eliminate tulip splay
- Features multiple Towers, to reduce
tissue disruption without compromising instrument strength
- Introduces unique MIS Lordotic
Visual Indicator Rods designed to confidently indicate sufficient
rod overhang
- Integrates with SingleStep
technique, which is designed to improve efficiency, reduce
radiation, and obviate the need for guide wires, which may lead to
complications
About Alphatec Holdings,
Inc.
Alphatec Holdings, Inc. (ATEC), through its
wholly-owned subsidiaries, Alphatec Spine,
Inc. and SafeOp Surgical, Inc., is a medical device
company dedicated to revolutionizing the approach to spine surgery
through clinical distinction. ATEC’s Organic Innovation Machine is
focused on developing new approaches that integrate seamlessly with
the SafeOp Neural InformatiX System to safely and reproducibly
treat spine’s various pathologies and achieve the goals of spine
surgery. Alphatec’s vision is to become the Standard Bearer in
Spine. For more information, visit us
at www.atecspine.com.
Forward Looking
Statements This press release
contains "forward-looking statements" within the meaning of the
Private Securities Litigation Reform Act of 1995 that involve risks
and uncertainty. Such statements are based on management's current
expectations and are subject to a number of risks and uncertainties
that could cause actual results to differ materially from those
described in the forward-looking statements. The Company cautions
investors that there can be no assurance that actual results will
not differ materially from those projected or suggested in such
forward-looking statements as a result of various factors.
Forward-looking statements include references to the Company’s
planned commercial launches, product introductions and product
integration, surgeon and market acceptance of Company products,
solutions and platforms, and the Company’s ability to deliver key
product features. The important factors that could cause
actual operating results to differ significantly from those
expressed or implied by such forward-looking statements include,
but are not limited to: the uncertainty of success in developing
new products or products currently in the Company’s pipeline;
failure to achieve acceptance of the Company’s products by the
surgeon community; failure to obtain FDA or other
regulatory clearance or approval for new products, or unexpected or
prolonged delays in the process; continuation of favorable third
party reimbursement for procedures performed using the Company’s
products; the Company’s ability to compete with other products and
with emerging new technologies; product liability exposure; patent
infringement claims; and claims related to the Company’s
intellectual property. The words “believe,” “will,” “should,”
“expect,” “intend,” “estimate,” “look forward” and “anticipate,”
variations of such words and similar expressions identify
forward-looking statements, but their absence does not mean that a
statement is not a forward-looking statement. A further list
and description of these and other factors, risks and uncertainties
can be found in the Company's most recent annual report, and any
subsequent quarterly and current reports, filed with
the Securities and Exchange Commission. ATEC disclaims any
intention or obligation to update or revise any forward-looking
statements, whether as a result of new information, future events,
or otherwise, unless required by law.
Company Contact:
Jeff BlackChief Financial OfficerAlphatec Holdings,
Inc. ir@atecspine.com
Investor/Media Contact:
Tina JacobsenInvestor Relations (760)
494-6790ir@atecspine.com
Alphatec (NASDAQ:ATEC)
Historical Stock Chart
From Mar 2024 to Apr 2024
Alphatec (NASDAQ:ATEC)
Historical Stock Chart
From Apr 2023 to Apr 2024